NUBURU, Inc. and Tailwind Acquisition Corp. Announce Closing of Business Combination

The combined company will operate under the “Nuburu, Inc.” name and its common stock and warrants will commence trading on February 1, 2023

BioSkryb Welcomes Accomplished Genomics Executive Suresh Pisharody as New CEO

Suresh Pisharody brings strong leadership experience honed at Illumina, Thermo Fisher Scientific, and Guardant Health to lead BioSkryb in its next phase of growth